Search results
Here are your search results for the keyword icw healthcare ventures
Quebec, leverages chemistry and machine learning to develop next-in-class mRNA therapeutics.Darbix develops modified mRNAs that provide therapeutic solutions to clinical conditions difficult to address with existing technology.The novel technology from Darbix harnesses the powers of chemistry and ma
June 01, 2026 by ICW Healthcare VenturesLongueuil, Quebec, ca
Quebec, leverages chemistry and machine learning to develop next-in-class mRNA therapeutics.Darbix develops modified mRNAs that provide therapeutic solutions to clinical conditions difficult to address with existing technology.The novel technology from Darbix harnesses the powers of chemistry and ma
June 01, 2026 by ICW Healthcare VenturesLongueuil, Quebec, ca
Quebec, leverages chemistry and machine learning to develop next-in-class mRNA therapeutics.Darbix develops modified mRNAs that provide therapeutic solutions to clinical conditions difficult to address with existing technology.The novel technology from Darbix harnesses the powers of chemistry and ma
June 01, 2026 by ICW Healthcare VenturesLongueuil, Quebec, ca
Quebec, leverages chemistry and machine learning to develop next-in-class mRNA therapeutics.Darbix develops modified mRNAs that provide therapeutic solutions to clinical conditions difficult to address with existing technology.The novel technology from Darbix harnesses the powers of chemistry and ma
June 01, 2026 by ICW Healthcare VenturesLaval, Quebec, ca
Quebec, leverages chemistry and machine learning to develop next-in-class mRNA therapeutics.Darbix develops modified mRNAs that provide therapeutic solutions to clinical conditions difficult to address with existing technology.The novel technology from Darbix harnesses the powers of chemistry and ma
June 01, 2026 by ICW Healthcare VenturesMontreal, Quebec, ca
Quebec, leverages chemistry and machine learning to develop next-in-class mRNA therapeutics.Darbix develops modified mRNAs that provide therapeutic solutions to clinical conditions difficult to address with existing technology.The novel technology from Darbix harnesses the powers of chemistry and ma
June 01, 2026 by ICW Healthcare VenturesMontreal, Quebec, ca
Quebec, leverages chemistry and machine learning to develop next-in-class mRNA therapeutics.Darbix develops modified mRNAs that provide therapeutic solutions to clinical conditions difficult to address with existing technology.The novel technology from Darbix harnesses the powers of chemistry and ma
June 01, 2026 by ICW Healthcare VenturesLaval, Quebec, ca
Quebec, leverages chemistry and machine learning to develop next-in-class mRNA therapeutics.Darbix develops modified mRNAs that provide therapeutic solutions to clinical conditions difficult to address with existing technology.The novel technology from Darbix harnesses the powers of chemistry and ma
June 01, 2026 by ICW Healthcare VenturesMontreal, Quebec, ca
Quebec, leverages chemistry and machine learning to develop next-in-class mRNA therapeutics.Darbix develops modified mRNAs that provide therapeutic solutions to clinical conditions difficult to address with existing technology.The novel technology from Darbix harnesses the powers of chemistry and ma
June 01, 2026 by ICW Healthcare VenturesLaval, Quebec, ca
Quebec, leverages chemistry and machine learning to develop next-in-class mRNA therapeutics.Darbix develops modified mRNAs that provide therapeutic solutions to clinical conditions difficult to address with existing technology.The novel technology from Darbix harnesses the powers of chemistry and ma
May 23, 2026 by ICW Healthcare VenturesMontreal, Quebec, ca